Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer.

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.

Cancers (Basel). 2019 May 10;11(5). pii: E648. doi: 10.3390/cancers11050648.

2.

Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases.

Santeufemia DA, Palmieri G, Cossu A, De Re V, Caggiari L, De Zorzi M, Casula M, Sini MC, Baldino G, Dedola MF, Corona G, Miolo G.

Diagnostics (Basel). 2019 Apr 11;9(2). pii: E42. doi: 10.3390/diagnostics9020042.

3.

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.

De Re V, Tornesello ML, De Zorzi M, Caggiari L, Pezzuto F, Leone P, Racanelli V, Lauletta G, Gragnani L, Buonadonna A, Vaccher E, Zignego AL, Steffan A, Buonaguro FM.

Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.

4.

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.

Corona G, Cannizzaro R, Miolo G, Caggiari L, De Zorzi M, Repetto O, Steffan A, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E750. doi: 10.3390/ijms19030750.

5.

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

Caggiari L, Miolo G, Buonadonna A, Basile D, Santeufemia DA, Cossu A, Palmieri G, De Zorzi M, Fornasarig M, Alessandrini L, Canzonieri V, Lo Re G, Puglisi F, Steffan A, Cannizzaro R, De Re V.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E47. doi: 10.3390/ijms19010047.

6.

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.

De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M.

Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1.

7.

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.

Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V.

Cancer Biol Ther. 2018 Apr 3;19(4):254-259. doi: 10.1080/15384047.2017.1394540. Epub 2017 Nov 13.

8.

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R.

Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303.

9.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

10.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128849. Beretta, Massimiliano [corrected to Berretta, Massimiliano].

11.

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.

De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, Berretta M, Gini A, Zucchetto A, Buonaguro FM, De Paoli P, Zignego AL.

Biomed Res Int. 2014;2014:710642. doi: 10.1155/2014/710642. Epub 2014 Feb 26.

12.

Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.

De Re V, Caggiari L, De Zorzi M, Talamini R, Racanelli V, D' Andrea M, Buonadonna A, Zagonel V, Cecchin E, Innocenti F, Toffoli G.

PLoS One. 2014 Jan 31;9(1):e84940. doi: 10.1371/journal.pone.0084940. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105850. PLoS One. 2014;9(3):e92487.

13.

Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.

Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M, Maiero S, Orzes E, Perin T, Zanussi S, De Paoli P, De Re V.

PLoS One. 2013 Oct 29;8(10):e77035. doi: 10.1371/journal.pone.0077035. eCollection 2013.

14.

Molecular signature in HCV-positive lymphomas.

De Re V, Caggiari L, Garziera M, De Zorzi M, Repetto O.

Clin Dev Immunol. 2012;2012:623465. doi: 10.1155/2012/623465. Epub 2012 Aug 16. Review.

15.

A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy.

Garziera M, De Re V, Geremia S, Seruca R, Figueiredo J, Melo S, Simões-Correia J, Caggiari L, De Zorzi M, Canzonieri V, Cannizzaro R, Toffoli G.

Clin Exp Med. 2013 May;13(2):149-57. doi: 10.1007/s10238-012-0184-7. Epub 2012 Apr 29.

PMID:
22543498
16.

KIR/HLA combination associated with the risk of complications in celiac disease.

Caggiari L, Toffoli G, De Re V, Orzes N, Spina M, De Zorzi M, Maiero S, Cannizzaro R, Canzonieri V.

Int J Biol Markers. 2011 Oct-Dec;26(4):221-8. doi: 10.5301/JBM.2011.8903.

PMID:
22180175
17.

Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.

Racanelli V, Brunetti C, De Re V, Caggiari L, De Zorzi M, Leone P, Perosa F, Vacca A, Dammacco F.

PLoS One. 2011;6(9):e25606. doi: 10.1371/journal.pone.0025606. Epub 2011 Sep 28.

18.
19.

HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa.

De Re V, Simula MP, Cannizzaro R, Sansonno D, Canzonieri V, Gloghini A, Carbone A, Colombatti A, Marin MD, De Zorzi M, Toffoli G.

Proteomics Clin Appl. 2008 Sep;2(9):1290-9. doi: 10.1002/prca.200800059. Epub 2008 Jul 21.

PMID:
21136923
20.

Protein expression changes in maize roots in response to humic substances.

Carletti P, Masi A, Spolaore B, Polverino De Laureto P, De Zorzi M, Turetta L, Ferretti M, Nardi S.

J Chem Ecol. 2008 Jun;34(6):804-18. doi: 10.1007/s10886-008-9477-4. Epub 2008 Jun 3.

PMID:
18521681

Supplemental Content

Loading ...
Support Center